Thursday, October 22, 2026 Published by AdvancedCare USA Inc.

TheraNews
Subscribe

Archive summary

SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus

Summary of reporting by timesargus 1 min read Markdown

SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus

Originally reported by timesargus. Read more

Source: https://www.timesargus.com/news/business/saphnelo-approved-in-the-us-for-subcutaneous-self-administration-as-a-new-autoinjector-for-the/article_818662b9-bb4f-58a1-bc54-632d1e158027.html

Newsletter

The weekly digest

Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.